Targeting T2 Inflammation by Dupilumab Impacts on the Microbiomic “Ménage À Trois” of Atopic Dermatitis

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2019.07.680
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Dupilumab for the Treatment of Atopic Dermatitis

Prescriber
Pharmacology
2018English

Alopecia Areata After Dupilumab for Atopic Dermatitis

JAAD Case Reports
Dermatology
2018English

Dupilumab-Induced Phenotype Switching From Atopic Dermatitis to Psoriasis

JAAD Case Reports
Dermatology
2020English

Targeting IgE Antibodies by Immunoadsorption in Atopic Dermatitis

Frontiers in Immunology
AllergyImmunology
2018English

La Regenta: Los Personajes Del Ménage À Trois

Fòrum de recerca
2016English

535 New Regional Dermatoses During Dupilumab Therapy for Atopic Dermatitis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Group 2 Innate Lymphoid Cells in Patients With Severe Atopic Dermatitis on Dupilumab

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Dupilumab in Atopic Dermatitis: Rationale, Latest Evidence and Place in Therapy

Therapeutic Advances in Chronic Disease
Medicine
2018English

673 Real-World Persistence With Dupilumab Among Adults With Atopic Dermatitis (AD)

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy